As a potent pharmaceutical active ingredient (API), Isotretinoin must strictly adhere to international pharmacopoeia standards such as USP (United States Pharmacopeia), EP (European Pharmacopoeia), or BP (British Pharmacopeia). Key specifications include a purity level of ≥98%, strict limits on related substances (impurities), and specific particle size distributions (often micronized) to ensure optimal bioavailability. Buyers must request a Certificate of Analysis (COA) for every batch to verify these parameters.